Table 3

 Blood levels after therapeutic and subtherapeutic CPAP

Change after therapeutic CPAPp valueChange after subtherapeutic CPAPp valueBetween group differencep value (between group changes)§
Values are mean (SD) with 95% confidence interval (CI).
*Laboratory reference range
†No laboratory reference range as new test
¶Non-fasting levels.
§Significance of the difference between the change in the two treatment groups (unpaired t test).
Cholesterol (mmol/l)3.9–7.8*−0.28 (0.88)(−0.45 to −0.11)n = 1060.001−0.07 (0.68)(−0.06 to 0.21)n = 1070.240.20(−0.12 to 0.41)0.06
Triglyceride (mmol/l)0.55–1.9* (fasting)−0.24 (0.26)¶(−0.28 to 0.76)n = 520.37−0.05 (1.4)¶(−0.45 to 0.36)n = 490.820.18(−0.50 to 0.86)0.60
FXIIa (ng/ml)†−0.08 (0.87)(−0.27 to 0.43)n = 260.65−0.14 (0.57)(−0.13 to 0.40)n = 200.30−0.13(−0.55 to 0.30)0.55
FVIIa (mU/ml)†2.38 (25.1)(−12.5 to 7.8)n = 260.63−18.3 (26.7)(5.05 to 31.6)n = 180.01−20.7(−36.6 to −4.8)0.01
s-Psel (ng/ml)†−4.23 (42.5)(−0.83 to 16.7)n = 470.50−7.3 (35.6)(−3.3 to 17.9)n = 460.173.10(−13.1 to 19.3)0.71
TAT (μg/l)†9.31 (43.5)(−26.9 to 8.24)n = 260.291.0 (42.9)(−21.1 to 19.0)n = 200.91−8.3(−34.2 to 17.7)0.52
vWF Ag (IU/dl)50–200*2.1 (22.4)(−8.9 to 4.7)n = 440.54−1.8 (24.0)(−5.3 to 8.9)n = 460.623.87(−5.9 to 13.6)0.61
Fibrinogen (g/l)1.5–4.0*0.05 (0.3)(−0.18 to 0.07)n = 260.37−0.03 (0.54)(−0.23 to 0.28)n = 200.84−0.08(−0.33 to 0.18)0.54
FVII (IU/dl)50–200*−5.3 (17.8)(−0.18 to 0.07)n = 260.140.7 (18.1)(−9.2 to 7.7)n = 200.866.0(−4.7 to 16.8)0.27
FVIII (IU/dl)50–200*−6.0 (19.5)(−1.9 to 13.9)n = 260.130.7 (19.4)(−9.8 to 8.4)n = 200.876.7(−5.0 to 18.3)0.26
FXII (IU/dl)50–200*−4.1 (16.6)(−2.6 to 10.8)n = 260.228.5 (15.7)(−15.8 to −1.1)n = 200.0312.5(2.8 to 22.2)0.01
Homocysteine (μmol/l)5–15*−0.64 (4.8)(−2.0 to 0.70)n = 520.340.26 (3.4)(−1.23 to 0.72)n = 490.600.18(−1.51 to 1.87)0.83